Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians
Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians
复制标题
DOI：
10.1016/j.jsat.2010.05.004
复制
发表时间：
2010-09-01
影响因子：
3.9
通讯作者：
Schuster, Charles Roberts
中科院分区：
文献类型：
--
作者：
Arfken, Cynthia L.;Johanson, Chris-Ellyn;Schuster, Charles Roberts
丁丙诺啡在办公室治疗阿片类药物依赖有可能扩大美国的治疗能力。然而，在全国范围内，很少有人知道有资格开丁丙诺啡的医生的数量、特点和经验。此外，人们对放宽联邦法规对医生被允许同时治疗的患者数量的影响知之甚少。为了解决这些问题，我们分析了2004-2008年全国范围内经认证开具丁丙诺啡的医生样本调查（N = 6892）。有资格开丁丙诺啡的医生数量持续增加，接受医生治疗的患者平均数量增加，被拒之门外的患者数量减少，这与联邦法规的暂时放松相吻合。此外，大多数医生在传统治疗环境之外开丁丙诺啡。美国将阿片类药物依赖的附表III-V药物扩展到正规药物滥用治疗机构之外的医生的实验似乎导致了能力的扩大。(C) 2010爱思唯尔公司版权所有。
Office-based treatment of opioid dependence with buprenorphine has the potential to expand treatment capacity in the United States. However, nationally, little is known about the number, characteristics, and experiences of physicians certified to prescribe buprenorphine. Moreover, little is known about the impact of easing federal regulations on the number of patients a physician is allowed to treat concurrently. To address these questions, surveys of national samples of physicians certified to prescribe buprenorphine (2004-2008) were analyzed (N = 6,892). There has been a continual increase in the number of physicians certified to prescribe buprenorphine, increase in the mean number of patients treated by physicians, and decrease in patients turned away, coinciding temporally with easing of federal regulations. In addition, most physicians prescribed buprenorphine outside of traditional treatment settings. The U.S. experiment in expanding Schedule III-V medications for opioid dependence to physicians outside of formal substance abuse treatment facilities appears to have resulted in expanded capacity. (C) 2010 Elsevier Inc. All rights reserved.